Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones
– On track to report interim Phase 1 data for VG-3927 in healthy volunteers in mid-2024 and Phase 2 results […]
Madrigal Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
CONSHOHOCKEN, Pa., Jan. 03, 2024 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics […]
ChampionX Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Schedule
THE WOODLANDS, Texas, Jan. 03, 2024 (GLOBE NEWSWIRE) — ChampionX Corporation (“ChampionX” or the “Company”) (NASDAQ: CHX) announced today that […]
Fenbo Holdings Limited Announces Appointment of Mr. Meng Derong as Co-Chairman and Independent Non-Executive Director
Hong Kong, Jan. 03, 2024 (GLOBE NEWSWIRE) — Fenbo Holdings Limited (the “Company” or “Fenbo”), an established provider of personal […]
BridgeBio Pharma to Participate in the J.P. Morgan Healthcare Conference
PALO ALTO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage […]
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
WALTHAM, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing […]
Cipher Mining Announces 60 MW Expansion of its Bear and Chief Joint Venture Data Centers and Purchase of 16,700 New Miners from Canaan Inc.
Bear LLC and Chief Mountain LLC Purchase ~2.5 EH/s of latest generation Canaan A1466 miners on favorable pricing and payment […]
HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting
Southlake, TX, Jan. 03, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the […]
Richardson Electronics Announces Date of Second Quarter Fiscal Year 2024 Conference Call
LAFOX, Ill., Jan. 03, 2024 (GLOBE NEWSWIRE) — Richardson Electronics, Ltd. (NASDAQ: RELL) plans to release its financial results for […]
Eterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)
CAMBRIDGE, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science […]
